E.E. Geduld’s Corbus Pharmaceuticals CRBP Stock Holding History

E.E. Geduld’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-833	Closed	-$41K	–	176
2015 Q4	$41K	Buy	+833	New	+$42.4K	0.03%	144

Other funds holding CRBP

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Yellowstone Partners Idaho Falls, Idaho $177M AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

E.E. Geduld's CRBP Position: Q1 2016 in Review

E.E. Geduld sold out of Corbus Pharmaceuticals (CRBP) in Q1 2016, closing a stake of 833 shares — an estimated $41K sold.

E.E. Geduld first reported a position in CRBP in Q4 2015 and held it in 1 quarter. The position peaked at $41K in Q4 2015. 22 funds tracked by Wall St. Rank hold CRBP as of Q1 2016.

E.E. Geduld reported no remaining Corbus Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
E.E. Geduld sold 833 Corbus Pharmaceuticals shares in Q1 2016, an estimated $41K.
E.E. Geduld first reported a position in Corbus Pharmaceuticals in Q4 2015 and held it in 1 quarter.
E.E. Geduld's Corbus Pharmaceuticals position peaked at $41K in Q4 2015.
22 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2016.

Based on E.E. Geduld's 13F filing for Q1 2016, filed 9 May 2016.